News

  • Blog: CNS Summit 2022 Boca was buzzing with patient-centricity

    Read More
  • uMotif announces first new validated innovation in eCOA/ePRO since paper instruments were deployed on smartphones

    Read More
  • Blog: ISPOR 2022 – The continued rise of the Patient Reported Outcome

    Read More
  • Blog: Digital Era Expands Scope and Impact for Medical Affairs. Prepare to Rise to the Challenge.

    Read More
  • uMotif experts to discuss the eCOA/ePRO market – what’s working, what’s wrong, and what patients need now

    Read More
  • Blog: Three things I learned at the PCMG 2022 assembly – “ The ‘I’ of the Storm”

    Read More
  • uMotif expands leadership team to support growth in US and EU markets

    Read More
  • uMotif and ClinOne Unify eCOA / ePRO and eConsent to Improve the Participant Experience and Endpoint Data Quality in Global Clinical Trials

    Read More
  • $25.5m of new investment from a fund managed by Athyrium Capital Management

    Read More